Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM21JVF)

Drug Name

Cbz-Glu(OtBu)-Ala-LeuVSMe Drug Info

Synonyms

CHEMBL208015; Cbz-Glu(OtBu)-Ala-LeuVSMe

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Cathepsin S (CTSS)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RG7625	DMDGPKS	Autoimmune disease	4A40-4A45	Phase 2	[2]
SAR-114137	DMZ1XR5	Pain	MG30-MG3Z	Phase 1	[3]
VBY- 891	DMTKPH4	Autoimmune diabetes	5A10	Phase 1	[4]
VBY- 036	DMULRYC	Neuropathic pain	8E43.0	Phase 1	[5]
VBY-129	DM4YIWK	Autoimmune diabetes	5A10	Phase 1	[6]
PMID27998201-Compound-12	DM8QZNC	Bone cancer	2B5Z	Patented	[7]
PMID27998201-Compound-5	DMVZ0ND	Chronic obstructive pulmonary disease	CA22	Patented	[7]
PMID27998201-Compound-9	DM1JOZN	Rheumatoid arthritis	FA20	Patented	[7]
PMID25399719-Compound-17	DMRXKJZ	N. A.	N. A.	Patented	[8]
PMID27998201-Compound-17	DMAZVHJ	Hair loss	ED70	Patented	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and c... J Med Chem. 2006 May 18;49(10):2953-68.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitor. Eur J Pharm Biopharm. 2013 Apr;83(3):436-48.
4	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2353).
5	Clinical pipeline report, company report or official report of ViroBay.
6	Clinical pipeline report, company report or official report of ViroBay.
7	Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
8	An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.